Koers Cascadian Therapeutics Inc (USA)

Aandelen

04-01-18	Cascadian Therapeutics Announces 2018 Outlook and Recent Progress
02-01-18	Cascadian Therapeutics Receives Pediatric Investigation Plan Waiver from the European Medicines Agency
13-12-17	Cascadian Therapeutics Added to the Nasdaq Biotechnology Index
07-12-17	Prolonged Progression-Free Survival Reinforces Tucatinib’s Potential for Patients with Advanced HER2+ Metastatic Breast Cancer
08-11-17	Cascadian Therapeutics Reports Third Quarter 2017 Financial Results

Toevoegen aan een lijst 0 geselecteerde Om deze functie te gebruiken moet u een klant of lid zijn. Inloggen Registreren	Verschil (%)	Varia. 5d.	Varia. 1j.	Varia. 3j.	Kap.($)
CASCADIAN THERAPEUTICS INC (USA)	-.--%	+0,50%	-	-	0
WUXI APPTEC CO., LTD.	-0,62%	-1,87%	+46,31%	+56,99%	63,77 mld.
ARGENX SE	+0,35%	+3,20%	+14,92%	+84,55%	56,37 mld.
LONZA GROUP AG	+0,53%	+1,96%	+15,37%	+106,81%	54,62 mld.
IQVIA HOLDINGS INC.	-2,81%	-4,31%	+23,50%	+47,83%	44,06 mld.
BEONE MEDICINES AG	-0,33%	-1,93%	+19,28%	+98,80%	42,11 mld.
REVOLUTION MEDICINES, INC.	+0,55%	+2,31%	+225,14%	+866,21%	41 mld.
GENMAB A/S	+3,27%	+47,96%	+112,67%	+96,48%	34,92 mld.
CELLTRION, INC.	+1,22%	-1,44%	+14,89%	+47,15%	32,82 mld.
INSMED INCORPORATED	+0,89%	+20,55%	-40,62%	+349,24%	24,7 mld.
Gemiddelde	+0,31%	+7,54%	+47,94%	+194,90%	43,82 mld.
Gewogen gemiddelde per kap.	+0,18%	+5,44%	+48,51%	+176,40%